Detail of "15641-58-4"

Reference

Linear or cyclic compounds useful for treating neurological disorders

Some chemicals with cas registry numbers like 15641-58-4 and 171722-69-3 are also used. Linear or cyclic compounds useful for treating neurological disorders. Bialer, Meir; Yagen, Boris; Winkler, Ilan; Devor, Marshall (Yissum Research Development Company of the Hebrew University of Jerusalem, Israel). PCT Int. Appl. WO 2005009430 A1 3 Feb 2005, 41 pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (English). (World Intellectual Property Organization). CODEN: PIXXD2. CLASS: ICM: A61K031-16. ICS: A61K031-19. APPLICATION: WO 2004-IL689 28 Jul 2004. PRIORITY: US 2003-PV490273 28 Jul 2003. DOCUMENT TYPE: Patent CA Section: 1 (Pharmacology) The invention relates to the use of compds. according to formula I [wherein (i) X is selected from OH and NR1R2; (ii) R1, R2 are independently selected from H and C1-C6 alkyl; and (iii) (a) R3, R4 are independently selected from H and C1-C6 alkyl; R5, R6 are independently selected from H and C1-C6 alkyl; or (b) one of R3 and R4, together with one of R5 and R6, form a cyclopropyl ring, and the other of R3, R4, R5 and R6 is selected from H and C1-C6 alkyl] for the prepn. of a medicament for treating neuropathic pain, migraine, and/or neuronal degeneration. The invention addnl. relates to a pharmaceutical compn. comprising these compds. for treating neuropathic pain, migraine, and/or neuronal degeneration. A method for treating neuropathic pain, migraine, and/or neuronal degeneration is also provided. .